Advertisement
Screener

SONOMA PHARMACEUTICALS, INC. (SNOA) Revenue from Related Parties

1.9 / 5 stars · 36/94 Roast Me

SONOMA PHARMACEUTICALS, INC. Revenue from Related Parties

SONOMA PHARMACEUTICALS, INC. (SNOA) reported Revenue from Related Parties of $741.00 thousand for the 3-month period ending 2013-06-30, per its 10-Q filed 2013-08-14.

Discontinued › Income Statement › Other Income

us-gaap:RevenueFromRelatedParties · last filed 2013-08-14

  • SONOMA PHARMACEUTICALS, INC. revenue from related parties for the quarter ending 2013-06-30 was $741.00K, a 34.77% decline year-over-year.
  • SONOMA PHARMACEUTICALS, INC. revenue from related parties for the quarter ending 2013-03-31 was $658.00K, a 31.95% decline year-over-year.
  • SONOMA PHARMACEUTICALS, INC. revenue from related parties for the quarter ending 2012-12-31 was $883.00K, a 32.78% increase year-over-year.
  • SONOMA PHARMACEUTICALS, INC. revenue from related parties for the quarter ending 2012-09-30 was $1.23M, a 4.51% increase year-over-year.
  • SONOMA PHARMACEUTICALS, INC. revenue from related parties for fiscal 2013 was $3.91M, a 16.01% increase from fiscal 2012.
  • SONOMA PHARMACEUTICALS, INC. revenue from related parties for fiscal 2012 was $3.37M.
Period endRevenue from Related Parties 3 monthRevenue from Related Parties 6 monthRevenue from Related Parties 9 monthRevenue from Related Parties 12 month
2013-06-30$741.00K
10-Q · filed 2013-08-14
$1.40M
derived: sum of 2 quarters · filed 2013-08-14
$2.28M
derived: sum of 3 quarters · filed 2013-08-14
$3.51M
derived: sum of 4 quarters · filed 2013-08-14
2013-03-31$658.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-06-25
$1.54M
derived: sum of 2 quarters · filed 2013-06-25
$2.77M
derived: sum of 3 quarters · filed 2013-06-25
$3.91M
10-K · filed 2013-06-25
2012-12-31$883.00K
10-Q · filed 2013-02-13
$2.11M
derived: sum of 2 quarters · filed 2013-02-13
$3.25M
10-Q · filed 2013-02-13
$4.21M
derived: sum of 4 quarters · filed 2013-08-14
2012-09-30$1.23M
10-Q · filed 2012-11-08
$2.37M
10-Q · filed 2012-11-08
$3.33M
derived: sum of 3 quarters · filed 2013-08-14
$4.00M
derived: sum of 4 quarters · filed 2013-08-14
2012-06-30$1.14M
10-Q · filed 2013-08-14
$2.10M
derived: sum of 2 quarters · filed 2013-08-14
$2.77M
derived: sum of 3 quarters · filed 2013-08-14
$3.94M
derived: sum of 4 quarters · filed 2013-08-14
2012-03-31$967.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-06-25
$1.63M
derived: sum of 2 quarters · filed 2013-06-25
$2.81M
derived: sum of 3 quarters · filed 2013-06-25
$3.37M
10-K · filed 2013-06-25
2011-12-31$665.00K
10-Q · filed 2013-02-13
$1.84M
derived: sum of 2 quarters · filed 2013-02-13
$2.40M
10-Q · filed 2013-02-13
2011-09-30$1.18M
10-Q · filed 2012-11-08
$1.74M
10-Q · filed 2012-11-08

Similar stocks

Stock NameCountryMarket CapPE Ratio
enVVeno Medical Corp (NVNO)United States$0.006B-0.48
INTELLIGENT BIO SOLUTIONS INC. (INBS)United States$0.005B
AETHLON MEDICAL INC (AEMD)United States$0.005B
Co-Diagnostics, Inc. (CODX)United States$0.007B-0.32
Bluejay Diagnostics, Inc. (BJDX)United States$0.004B
OSR Health, Inc. (OSRH)United States$0.004B-0.75
Adagio Medical Holdings, Inc. (ADGM)United States$0.004B
Autonomix Medical, Inc. (AMIX)United States$0.004B
Beyond Air, Inc. (XAIR)United States$0.003B-0.01
Vivos Therapeutics, Inc. (VVOS)United States$0.003B-0.26